The Results of Surgery, With or Without Radiotherapy, for Primary Spinal Myxopapillary Ependymoma: A Retrospective Study From the Rare Cancer Network

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 4, 2009, Pages 1114-1120

  Pica, Alessia ^a   Miller, Robert ^b   VillÀ, Salvador ^c   Kadish, Sidney P ^d   Anacak, Yavuz ^e   Abusaris, Huda ^f   Ozyigit, Gokhan ^g   Baumert, Brigitta G ^h   Zaucha, Renata ⁱ   Haller, Guy ^j   Weber, Damien C ^j  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b MAYO CLINIC   (United States)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^f DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^g HACETTEPE UNIVERSITY   (Turkey)

^h MAASTRICHT UNIVERSITY   (Netherlands)

ⁱ MEDICAL UNIVERSITY OF GDANSK   (Poland)

^j GENEVA UNIVERSITY HOSPITALS   (Switzerland)

more..

Author keywords

Myxopapillary ependymoma; Radiation therapy; Spinal tumor

Indexed keywords

BRAIN COMPONENTS; EPENDYMOMA; HIGH DOSE; INDEPENDENT PREDICTORS; LOCAL FAILURE; MULTI VARIATE ANALYSIS; MULTICENTER STUDY; MYXOPAPILLARY EPENDYMOMA; POSTOPERATIVE RADIOTHERAPY; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION THERAPY; SPINAL TUMOR; TREATMENT FAILURE; TUMOR PROGRESSIONS; TUMOR SIZE; UNIVARIATE ANALYSIS;

DECISION MAKING; INFRARED SPECTROMETERS; MULTIVARIANT ANALYSIS; RADIOTHERAPY; SURGERY; TUMORS;

DOSIMETRY;

ADOLESCENT; ADULT; AGE; AGED; AMENORRHEA; ARTICLE; ASTHENIA; ATAXIA; BACKACHE; BRAIN; BRAIN DYSFUNCTION; BROWN SEQUARD SYNDROME; CHILD; CHRONIC PAIN; CLINICAL FEATURE; CLINICAL TRIAL; ENTERITIS; EPENDYMOMA; ERYTHEMA; ESOPHAGITIS; FECES INCONTINENCE; FEMALE; GAIT DISORDER; GASTRITIS; GENDER; HUMAN; HYPESTHESIA; LEG; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MUSCLE ATROPHY; MUSCULOSKELETAL PAIN; NAUSEA; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; OVERALL SURVIVAL; PARAPLEGIA; PARESIS; PARESTHESIA; PERITONITIS; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; SCHOOL CHILD; SCOLIOSIS; SKIN FIBROSIS; SPINAL CORD; SPINAL CORD DISEASE; SPINAL CORD TUMOR; THORAX OUTLET SYNDROME; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME; UNIVARIATE ANALYSIS; URINE INCONTINENCE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BRAIN NEOPLASMS; CHILD; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EPENDYMOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SPINAL NEOPLASMS; TREATMENT FAILURE; YOUNG ADULT;

EID: 67649566410     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.09.034     Document Type: Article

References (30)

1. Kleihues P., and Sobin L.H. World Health Organization classification of tumors. Cancer 88 (2000) 2887
2. Kahan H., Sklar E.M., Post M.J., et al. MR characteristics of histopathologic subtypes of spinal ependymoma. AJNR Am J Neuroradiol 17 (1996) 143-150
3. Gilhuis H.J., van der Laak J., Wesseling P., et al. Inverse correlation between genetic aberrations and malignancy grade in ependymal tumors: A paradox?. J Neurooncol 66 (2004) 111-116
4. Hirose Y, Aldape K, Bollen A, et al. Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. 2001;158;1137-1143.
5. Yu Y.L., Crockard H.A., Smith J.J., et al. Extraspinal ependymoma at the cervicothoracic junction. Surg Neurol 17 (1982) 160-162
6. Schroder R., Firsching R., and Kochanek S. Hemangiopericytoma of meninges. II. General and clinical data. Zentralbl Neurochir 47 (1986) 191-199
7. Warnick R.E., Raisanen J., Adornato B.T., et al. Intracranial myxopapillary ependymoma: case report. J Neurooncol 15 (1993) 251-256
8. Akyurek S., Chang E.L., Yu T.K., et al. Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center. J Neurooncol 80 (2006) 177-183
9. Sonneland P.R., Scheithauer B.W., and Onofrio B.M. Myxopapillary ependymoma. A clinicopathologic and immunocytochemical study of 77 cases. Cancer 56 (1985) 883-893
10. Woesler B., Moskopp D., Kuchelmeister K., et al. Intracranial metastasis of a spinal myxopapillary ependymoma. A case report. Neurosurg Rev 21 (1998) 62-65
11. Jatana K.R., Jacob A., Slone H.W., et al. Spinal myxopapillary ependymoma metastatic to bilateral internal auditory canals. Ann Otol Rhinol Laryngol 117 (2008) 98-102
12. Wight D.G., Holley K.J., and Finbow J.A. Metastasizing ependymoma of the cauda equina. J Clin Pathol 26 (1973) 929-935
13. Plans G., Brell M., Cabiol J., et al. Intracranial retrograde dissemination in filum terminale myxopapillary ependymomas. Acta Neurochir (Wien) 148 (2006) 343-346 discussion 346
14. Frankel H.L., Hancock D.O., Hyslop G., et al. The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. I. Paraplegia 7 (1969) 179-192
15. Peto R., Pike M.C., Armitage P., et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35 (1977) 1-39
16. Cox D. Regression models and life tables. J R Stat Soc 34 (1972) 187-220
17. Helwig E.B., and Stern J.B. Subcutaneous sacrococcygeal myxopapillary ependymoma. A clinicopathologic study of 32 cases. Am J Clin Pathol 81 (1984) 156-161
18. Nakamura M., Ishii K., Watanabe K., et al. Surgical treatment of intramedullary spinal cord tumors: prognosis and complications. Spinal Cord 46 (2008) 282-286
19. Schild S.E., Wong W., and Nisi K. In regard to the radiotherapy of myxopapillary ependymomas. Int J Radiat Oncol Biol Phys 53 (2002) 787
20. Vanuytsel L., and Brada M. The role of prophylactic spinal irradiation in localized intracranial ependymoma. Int J Radiat Oncol Biol Phys 21 (1991) 825-830
21. Paulino A.C., and Wen B.C. The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys 47 (2000) 585-589
22. Shaw E.G., Evans R.G., Scheithauer B.W., et al. Postoperative radiotherapy of intracranial ependymoma in pediatric and adult patients. Int J Radiat Oncol Biol Phys 13 (1987) 1457-1462
23. Kovalic J.J., Flaris N., Grigsby P.W., et al. Intracranial ependymoma long term outcome, patterns of failure. J Neurooncol 15 (1993) 125-131
24. Waldron J.N., Laperriere N.J., Jaakkimainen L., et al. Spinal cord ependymomas: A retrospective analysis of 59 cases. Int J Radiat Oncol Biol Phys 27 (1993) 223-229
25. Monoranu C.-M., Huang B., Zangen I.L., et al. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas. Cancer Genet Cytogenet 182 (2008) 18-26
26. Pezzolo A., Capra V., Raso A., et al. Identification of novel chromosomal abnormalities and prognostic cytogenetics markers in intracranial pediatric ependymoma. Cancer Lett 261 (2008) 235-243
27. Gavin Quigley D., Farooqi N., Pigott T.J., et al. Outcome predictors in the management of spinal cord ependymoma. Eur Spine J 16 (2007) 399-404
28. Hall W.A., Merrill M.J., Walbridge S., et al. Epidermal growth factor receptors on ependymomas and other brain tumors. J Neurosurg 72 (1990) 641-646
29. Gilbertson R.J., Bentley L., Hernan R., et al. ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease. Clin Cancer Res 8 (2002) 3054-3064
30. Mendrzyk F., Korshunov A., Benner A., et al. Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma. Clin Cancer Res 12 (2006) 2070-2079